HFA Premium Access

The prognostic value of sodium-glucose co-transporter-2 inhibitors therapy among patients with cancer and diabetes mellitus, treated with immune checkpoint inhibitors

Congress Presentation

About the speaker

Doctor Michal Laufer-Perl

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)
0 follower

6 more presentations in this session

A new maternal heart clinic - early experiences and challenges in a quaternary hospital in Western Australia.

Speaker: Doctor R. Chetty (Perth, AU)


Safety and utility of cardiopulmonary exercise testing in non-Hodgkin lymphoma patients undergoing chemotherapy

Speaker: Doctor D. Bursacovschi (Chisinau, MD)


Plasminogen activator inhibitor -1 and circulating ceruloplasmin levels in men with heart failure with preserved ejection fraction with concomitant prostate cancer

Speaker: Doctor O. Sirenko (Dnipro, UA)


Relationship between clinical and echocardiographic outcomes and cardioprotective drugs in a population of female breast cancer patients exposed to anthracyclines

Speaker: Doctor C. Oliveira (Porto, PT)


Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients

Speaker: Doctor A. Cuomo (Napoly, IT)


Access the full session

ePosters in cardiovascular disease in special populations 1

Speakers: Doctor M. Laufer-Perl, Doctor R. Chetty, Doctor D. Bursacovschi, Doctor O. Sirenko, Doctor C. Oliveira...

About the event


Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by